Samsung invests in Exo to develop ultrasound technology

According to a statement confirming a previous report by Bloomberg News, Samsung Medison has reached a strategic cooperation with Exo Imaging, a company based in California. The statement mentioned that the cooperation includes Samsung's strategic equity investment to accelerate the development of the next-generation ultrasound platform. Omar Ishrak will join the Exo board as strategic chairman. Ishrak previously served as the CEO of Medtronic and GE Healthcare. Samsung Medison CEO Ryu Gye-tae stated that this cooperation "marks an important step in advancing the transformation of the ultrasound imaging field." Ishrak added that Exo's technology is expected to significantly enhance diagnostic accuracy and accessibility